Cardiology

Study results show that newly initiated combined antiretroviral therapy (ART) in treatment-naïve patients with HIV appears to not effectively prevent the progression of significant arterial inflammation.

New analysis of data from the Framingham Heart Study found a significant association between atrial fibrillation (AF) and reduced volume in the brain’s frontal lobe.

After 6 months, an intervention program based on the Dietary Approaches to Stop Hypertension (DASH) diet increased the proportion of participants with uncontrolled asthma who achieved minimal clinically important improvement in asthma control.

A retrospective analysis of diabetes and prediabetes diagnoses found that screening guidelines from the United States Preventative Service Task Force (USPSTF) would have detected less than half of all cases that were discovered.

Public health issues are nothing new in the medical community, but for issues like high sodium levels the pressing issue can be what to do to help bring the levels to healthier levels.

The intake of sodium is becoming a greater problem across the world, but especially in the United States. While people for the most part are not adding sodium to the food themselves the processed foods they are eating contain more sodium than they did in the past.

Researchers have found a treasure trove of information posted by people on Facebook, Twitter and other online forums. Is it ethical, legal, or scientifically valid to create research studies using such postings?

It's time to redirect the initial evaluation of low- to intermediate-risk patients presenting with symptoms suggestive of CAD back to the primary care and internal medicine setting.

Once hepatitis C is cured, patients' risk for portal vein hypertension drops – along with the accompanying complications.

A new study published in JAMA Internal Medicine found that most patients who visit the emergency room for nontraumatic chest pain are rarely in a life-threatening situation.

The American College of Cardiology and American Heart Association have released new clinical performance and quality measures designed to speed the adoption of guidelines issued last year for the treatment of atrial fibrillation.

It was just three years ago that the American College of Cardiology approved new guidelines regarding lowering cholesterol levels. However, in that time new treatments have been approved necessitating the implementation of new potential methods to help this patient population.

The approval of medications like statins and PCSK9 inhibitors to help lower cholesterol levels have proven helpful but a recent study looked at whether patients were getting not only the treatments they needed but whether they were getting the right dosage levels to help improve their health.

For many years, warfarin has been the primary option for anticoagulation, but recently newer medications have been approved that may provide better options for this patient population. While the clinical trials of the novel oral anticoagulant drugs showed positive results, there were still lingering questions about how they would fare in the field.

In a very short period of time a lot has been learned that can help people diagnosed with atrial fibrillation. For as much work has been done in the field it is only useful if it reaches patients in need which can be an issue no matter where they live.